Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $14.01 billion. The enterprise value is $13.56 billion.

Market Cap	14.01B
Enterprise Value	13.56B

Important Dates

The last earnings date was Wednesday, October 30, 2024, before market open.

Earnings Date	Oct 30, 2024
Ex-Dividend Date	n/a

Share Statistics

SMMT has 737.45 million shares outstanding. The number of shares has increased by 28.70% in one year.

Current Share Class	737.45M
Shares Outstanding	737.45M
Shares Change (YoY)	+28.70%
Shares Change (QoQ)	+2.65%
Owned by Insiders (%)	80.14%
Owned by Institutions (%)	11.57%
Float	105.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	31.98
P/TBV Ratio	32.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.31, with a Debt / Equity ratio of 0.07.

Current Ratio	8.31
Quick Ratio	8.26
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.69

Financial Efficiency

Return on equity (ROE) is -73.21% and return on invested capital (ROIC) is -33.55%.

Return on Equity (ROE)	-73.21%
Return on Assets (ROA)	-31.47%
Return on Capital (ROIC)	-33.55%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	105
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +859.60% in the last 52 weeks. The beta is -0.92, so SMMT's price volatility has been lower than the market average.

Beta (5Y)	-0.92
52-Week Price Change	+859.60%
50-Day Moving Average	20.89
200-Day Moving Average	10.82
Relative Strength Index (RSI)	46.02
Average Volume (20 Days)	2,058,005

Short Selling Information

Short Interest	17.04M
Short Previous Month	15.45M
Short % of Shares Out	14.34%
Short % of Float	n/a
Short Ratio (days to cover)	5.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-181.59M
Pretax Income	-161.69M
Net Income	-196.68M
EBITDA	-181.49M
EBIT	-181.59M
Earnings Per Share (EPS)	-$0.28

Full Income Statement

Balance Sheet

The company has $486.90 million in cash and $32.50 million in debt, giving a net cash position of $454.40 million or $0.62 per share.

Cash & Cash Equivalents	486.90M
Total Debt	32.50M
Net Cash	454.40M
Net Cash Per Share	$0.62
Equity (Book Value)	437.92M
Book Value Per Share	0.59
Working Capital	431.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.89 million and capital expenditures -$127,000, giving a free cash flow of -$113.02 million.

Operating Cash Flow	-112.89M
Capital Expenditures	-127,000
Free Cash Flow	-113.02M
FCF Per Share	-$0.15

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.70%
Shareholder Yield	-28.70%
Earnings Yield	-1.40%
FCF Yield	-0.81%

Dividend Details

Analyst Forecast

The average price target for SMMT is $34.75, which is 82.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.75
Price Target Difference	82.90%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-27.14%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2